Filter
2682
Text search:
poor
quality
medicines
Featured
Recommendations
290
New Publications
835
Language
Document type
No document type
1490
Studies & Reports
473
Guidelines
335
Manuals
139
Strategic & Response Plan
135
Training Material
46
Fact sheets
29
Situation Updates
20
Resource Platforms
6
Infographics
6
Brochures
2
Online Courses
1
Countries / Regions
India
147
Global
122
Kenya
98
South Africa
82
Ethiopia
79
Uganda
72
Nepal
58
Bangladesh
55
Sierra Leone
54
Nigeria
54
Ghana
54
Malawi
53
Tanzania
51
Myanmar / Burma
49
Africa
49
Liberia
48
Zambia
47
Western and Central Europe
43
Namibia
41
Rwanda
32
Latin America and the Carribbean
27
Syria
25
Ukraine
25
Philippines
24
Congo, Democratic Republic of
21
Cambodia
21
Mozambique
20
Zimbabwe
18
Lesotho
18
South–East Asia Region
18
Eastern Europe
17
Haiti
16
Asia
16
Indonesia
15
Senegal
11
South Sudan
11
Botswana
11
Guinea
10
Pakistan
10
Sudan
10
Eswatini/ Swaziland
9
Middle East and North Africa
9
Burkina Faso
8
East and Southern Africa
8
Vietnam
8
Afghanistan
7
Brazil
7
Venezuela
7
North America
7
Cameroon
6
Somalia
6
Lebanon
6
Yemen
6
Eastern Europe and Central Asia
6
Georgia
6
Jordan
5
Thailand
5
West and Central Africa
5
Western Pacific Region
5
Laos
5
Benin
4
Peru
4
Albania
4
Southern Africa
4
Russia
4
Iraq
3
China
3
Central African Republic
3
North Macedonia
3
Sri Lanka
3
Bhutan
3
Palestine
3
Timor Leste/ East Timor
3
Tajikistan
3
Kyrgyzstan
3
Jamaica
3
Morocco
2
Germany
2
Hungary
2
Colombia
2
Bolivia
2
Mexico
2
Paraguay
2
Poland
2
Moldova
2
Iran
2
Mauritius
2
United Kingdom
2
Saudi Arabia
1
Turkey
1
Egypt
1
Chad
1
Gambia
1
Papua New Guinea
1
Argentina
1
Burundi
1
Ecuador
1
El Salvador
1
Greece
1
Libya
1
Madagascar
1
Chile
1
Other region
1
Fiji
1
Mongolia
1
Canada
1
Qatar
1
Lithuania
1
Kazakhstan
1
Denmark
1
Tunisia
1
Norway
1
Portugal
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
1182
Clinical Guidelines
237
Public Health
188
Women & Child Health
131
Key Resources
91
Capacity Building
50
Pharmacy & Technologies
27
Annual Report MEDBOX
1
Toolboxes
HIV
199
TB
196
AMR
138
Mental Health
134
COVID-19
119
Pharmacy
98
NCDs
86
NTDs
71
Caregiver
70
Disability
66
Planetary Health
62
Conflict
54
Global Health Education
51
Malaria
49
Health Financing Toolbox
40
Ebola & Marburg
36
Refugee
34
Natural Hazards
25
Rapid Response
20
Polio
11
2.0 Rapid Response
10
Cholera
9
Zika
4
Social Ethics
4
Specific Hazards
3
Typhoon
1
NATIONAL TUBERCULOSIS AND LEPROSY PROGRAMME
Public health challenges over the past decade have highlighted the importance of approaching health through a holistic lens of human, animal, and environmental sectors, recognizing the need for a collaborative response against shared threats. Zoonotic diseases, transmitted between humans and animals
...
EDCTP Stakeholder meeting
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
The Country Cooperation Strategy is the World Health Organization (WHO)’s reference for country work guiding planning and resource allocation through alignment with national health priorities and harmonization with other development partners. It clarifies roles and functions of WHO in supporting t
...
This situation analysis has gathered information about the current state of AMR, contributing factors and antimicrobial use in Zimbabwe from the human, animal, agricultural and environmental sectors. Data has been gathered from different sectors such as the general public, academia, the Ministry of
...
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight against AMR, FIP has prepared this
briefing document. It is an overview of the different activities
...
Sepsis contributes significantly to preventable mortality and is the final common pathway to death for severe infectious diseases; it can also arise as a complication of injuries and non-communicable diseases.
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
Technical Brief
The Country Cooperation Strategy is the World Health Organization’s corporate framework developed in response to a country’s needs and priorities. The 2022–2025 CCS is the fourth for WHO in Sierra Leone. It is a medium-term strategic document that defines a broad framework for WHO’s work, at
...
The use of the World Health Organization Health System Performance Assessment Framework